Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Remdesivir
Enzyme assay
Approved by FDA Experimental Antiviral Jan/18/2023
Nirmatrelvir
Enzyme assay
Emergency use authorization Experimental Antiviral Jun/23/2022
ACE2‐Fc
Enzyme assay
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/26/2022
Ivermectin
Enzyme assay
Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022
PF-00835231
Enzyme assay
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
N(4)-Hydroxycytidine
Enzyme assay
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
Ritonavir
Enzyme assay
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Favipiravir
Enzyme assay
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Enzyme assay
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
GC376
Enzyme assay
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
Naphthazarin
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021
Menadione
Enzyme assay
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021
Anacardic acid
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Sciadopitysin
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ginkgo biloba leaves extract
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ginkgolic acid C17:1
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Camostat mesylate
Enzyme assay
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021
Ambroxol
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021
Lopinavir
Enzyme assay
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021
Baicalein
Enzyme assay
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021